No serious side effects in Merck/Newlink Ebola vaccine test
Tuesday, December 2, 2014 - 12:00
in Health & Medicine
LONDON (Reuters) - The first people vaccinated with an experimental Ebola shot being developed by Merck and NewLink have had no serious side effects so far, but a few experienced mild fever, Swiss researchers said on Tuesday.
